home / stock / hook / hook news

HOOK News and Press, HOOKIPA Pharma Inc. From 09/09/20

Stock Information
Company Name: HOOKIPA Pharma Inc.
Stock Symbol: HOOK
Market: NASDAQ
Website: hookipapharma.com
Menu
HOOK HOOK Quote HOOK Short HOOK News HOOK Articles HOOK Message Board
Get HOOK Alerts

News, Short Squeeze, Breakout and More Instantly...
HOOK - HOOKIPA Pharma to Present at Upcoming Conferences in September

NEW YORK and VIENNA, Austria, Sept. 09, 2020 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing a new class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform, today announced that H...
HOOK - HOOKIPA Pharma EPS beats by $0.19, beats on revenue

HOOKIPA Pharma (NASDAQ: HOOK ) : Q2 GAAP EPS of -$0.28 beats by $0.19 . More news on: HOOKIPA Pharma Inc., Earnings news and commentary, Healthcare stocks news, Read more ...

HOOK - HOOKIPA Pharma Reports Second Quarter 2020 Financial Results and Provides a Corporate Update

NEW YORK and VIENNA, Austria, Aug. 13, 2020 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing a new class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform, today reports its finan...

HOOK - HOOKIPA Pharma To Report Second Quarter 2020 Financial Results on August 13, 2020

NEW YORK and VIENNA, Austria, Aug. 04, 2020 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing a new class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform, today announced that it...
HOOK - HOOKIPA announces issuance of patents from US and EU

HOOKIPA Pharma (NASDAQ: HOOK ) announces that US and Europe have issued patents covering the company’s proprietary replicating arenavirus technology. More news on: HOOKIPA Pharma Inc. Read more ...

HOOK - HOOKIPA Announces Issuance of US and European Patents

NEW YORK and VIENNA, Austria, Aug. 03, 2020 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing a new class of immunotherapeutics targeting infectious diseases and cancers, today announced that both the United States Patent and Trademark Off...

HOOK - Evelo Trial Progress, And Other News: The Good, Bad And Ugly Of Biopharma

Evelo Bio Moves Ahead with EDP1815 Mid Stage Trial Evelo Biosciences Inc. ( EVLO ) announced that its lead drug candidate EDP1815 will now be a part of TACTIC-E clinical trial. The trial is designed to assess the safety and efficacy of certain experimental therapies in the preventing and...
HOOK - Hookipa lead candidate shows positive action in mid-stage study

HOOKIPA Pharma (NASDAQ: HOOK ) announces positive preliminary data from a Phase 2 clinical trial evaluating cytomegalovirus (CMV) vaccine candidate HB-101 in patients receiving a transplanted kidney from a live donor. More news on: HOOKIPA Pharma Inc., Healthcare stocks news, Stocks on...

HOOK - HOOKIPA Announces Positive Phase 2 Interim Safety and Immunogenicity Results for its CMV Vaccine Candidate HB?101

Interim data demonstrate that HB‑101 is well tolerated HB-101 elicits T cell and B cell responses in the target population NEW YORK and VIENNA, Austria, June 22, 2020 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing a new cla...

HOOK - HOOKIPA Announces Changes to its Board of Directors - Resignation of Sander van Deventer

NEW YORK and VIENNA, Austria, June 19, 2020 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing a new class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform, today announced that Dr...
Previous 10 Next 10